Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3

Date : 05/28/2008 @ 4:05PM
Source : PR Newswire
Stock : Sequenom (MM) (SQNM)
Quote : 21.37  -1.71 (-7.41%) @ 10:49AM
<< BackQuote Chart Financials

 



Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3

SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Sequenom, Inc. (NASDAQ:SQNM) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst and investor briefing event "Sequenom: The Future of Noninvasive Prenatal Diagnostics." Details of the event are as follows:

What: Sequenom: The Future of Noninvasive Prenatal Diagnostics

When: Tuesday, June 3, 2008 at 6:00 p.m. Pacific time

Where: http://www.sequenom.com/

Agenda: Hosted by: Harry Stylli, Ph.D., Chief Executive Officer of Sequenom, Inc.

Presenters: Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine Brown University Medical School "Methods for screening pregnancies for Down syndrome"

Allan T. Bombard, MD, FACOG, FACS, FACMG, Chief Medical Officer, Sharp Mary Birch Hospital; Adjunct Professor, Obstetrics and Gynecology/SUNY Downstate Medical Center; Clinical Professor, Albert Einstein College of Medicine "Current clinical practice for Down syndrome screening and diagnosis"

Betty Dragon, Ph.D., Senior Vice President, Research & Development of Sequenom, Inc.

"Sequenom's SEQureDx: A noninvasive prenatal diagnostic test for Down syndrome. Technical Achievements, Milestones and Future Challenges"

Dennis Lo, Consultant to Sequenom, Inc.

"The future of prenatal diagnosis: Progress through fetal nucleic acids"

How: Live over the Internet - Simply log on to the web at the address above. Presentation will be archived.

Contact: Lippert/Heilshorn & Associates Jody Cain () 310-691-7100

About Sequenom

Sequenom is committed to providing the best genetic analysis products for research and the molecular diagnostic markets. The Company makes available superior solutions for genomic science in biomedical research, livestock and agricultural applications and molecular medicine, as well as for various diagnostic markets, including noninvasive prenatal testing, oncology and infectious diseases. Sequenom's proprietary MassARRAY(R) system delivers reliable and specific data from complex biological samples and from genetic target materials available only in trace amounts.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com/ and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an E-mail to: .

http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO

http://photoarchive.ap.org/

DATASOURCE: Sequenom, Inc.

CONTACT: Jody Cain of LippertHeilshorn & Associates, +1-310-691-7100,

Web site: http://www.sequenom.com/

<< Back


Sequenom (MM) Historical Chart Sequenom (MM) Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us 081006 11:04 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )